These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 33893077)
1. Contribution of Wu MH; Yueh TC; Chang WS; Tsai CW; Fu CK; Yang MD; Yu CC; Bau DT Cancer Genomics Proteomics; 2021; 18(3):245-251. PubMed ID: 33893077 [TBL] [Abstract][Full Text] [Related]
2. The Significant Association of Tsai CB; Hsia NY; Wang YC; Wang ZH; Chin YT; Huang TL; Yu CC; Chang WS; Tsai CW; Yin MC; Bau DT Anticancer Res; 2020 Feb; 40(2):703-707. PubMed ID: 32014911 [TBL] [Abstract][Full Text] [Related]
3. The Association of Hsiao CL; Liu LC; Shih TC; Lai YL; Hsu SW; Wang HC; Pan SY; Shen TC; Tsai CW; Chang WS; Su CH; Way TD; Chung JG; Bau DT In Vivo; 2018; 32(3):487-491. PubMed ID: 29695550 [TBL] [Abstract][Full Text] [Related]
4. The Association of Matrix Metalloproteinase-1 Promoter Polymorphisms with Prostate Cancer in Taiwanese Patients. Liao CH; Wu HC; Hu PS; Hsu SW; Shen TC; Hsia TC; Chang WS; Tsai CW; Bau DT Anticancer Res; 2018 Jul; 38(7):3907-3911. PubMed ID: 29970511 [TBL] [Abstract][Full Text] [Related]
5. E-cadherin and metalloproteinase-1 and -7 polymorphisms in colorectal cancer. de Lima JM; de Souza LG; da Silva ID; Forones NM Int J Biol Markers; 2009; 24(2):99-106. PubMed ID: 19634113 [TBL] [Abstract][Full Text] [Related]
6. The Contribution of Yueh TC; Wu CN; Hung YW; Chang WS; Fu CK; Pei JS; Wu MH; Lai YL; Lee YM; Yen ST; Li HT; Tsai CW; Bau DT Cancer Genomics Proteomics; 2018; 15(3):207-212. PubMed ID: 29695403 [TBL] [Abstract][Full Text] [Related]
7. Matrix Metalloproteinase-1 Genotype Contributes to the Risk of Non-solid Tumor in Childhood Leukemia. Pei JS; Hsu PC; Chou AK; Tsai CW; Chang WS; Hsiao CL; Hsu YN; Cheng SP; Bau DT Anticancer Res; 2016 Oct; 36(10):5127-5132. PubMed ID: 27798872 [TBL] [Abstract][Full Text] [Related]
8. The Contribution of Matrix Metalloproteinase-1 Promoter Genotypes in Taiwan Lung Cancer Risk. Shen TC; Chang WS; Tsai CW; Chao CY; Lin YT; Hsiao CL; Hsu CL; Chen WC; Hsia TC; Bau DT Anticancer Res; 2018 Jan; 38(1):253-257. PubMed ID: 29277780 [TBL] [Abstract][Full Text] [Related]
9. The Contribution of Matrix Metalloproteinase-1 Genotypes to Hepatocellular Carcinoma Susceptibility in Taiwan. Lai YL; Gong CL; Fu CK; Yueh TC; Tsai CW; Chang WS; Hsiao CL; Yen ST; Li HT; Jeng LB; Wang SC; Bau DT Cancer Genomics Proteomics; 2017; 14(2):119-125. PubMed ID: 28387651 [TBL] [Abstract][Full Text] [Related]
10. Matrix metalloproteinase-1 polymorphism (-1607G) and disease severity in non-cystic fibrosis bronchiectasis in Taiwan. Hsieh MH; Chou PC; Chou CL; Ho SC; Joa WC; Chen LF; Sheng TF; Lin HC; Wang TY; Chang PJ; Wang CH; Kuo HP PLoS One; 2013; 8(6):e66265. PubMed ID: 23776649 [TBL] [Abstract][Full Text] [Related]
11. Association of Matrix Metalloproteinase-1 Genotypes With Bladder Cancer Risk. Liao CH; Tsai CW; Chang WS; Wang ZH; Gong CL; Wu HC; Wang BR; Hsu SW; Huang WC; Shen TC; Bau DT In Vivo; 2021; 35(5):2535-2540. PubMed ID: 34410940 [TBL] [Abstract][Full Text] [Related]
12. Impact of Matrix Metalloproteinase-8 Genotypes on Colorectal Cancer Risk in Taiwan. Deng Y; Ke TW; Wang YC; Chin YT; Yueh TC; Hung YC; Mong MC; Yang YC; Chang WS; Shen TC; Bau DT; Tsai CW Anticancer Res; 2023 Sep; 43(9):3979-3985. PubMed ID: 37648297 [TBL] [Abstract][Full Text] [Related]
13. Matrix metalloproteinase-1 polymorphism is associated with persistent airway obstruction in asthma in the Taiwanese population. Huang CD; Lin SM; Chang PJ; Liu WT; Wang CH; Liu CY; Lin HC; Hsieh LL; Kuo HP J Asthma; 2009 Feb; 46(1):41-6. PubMed ID: 19191136 [TBL] [Abstract][Full Text] [Related]
14. Matrix metalloproteinase-1 promoter polymorphism 1G/2G is correlated with colorectal cancer invasiveness. Ghilardi G; Biondi ML; Mangoni J; Leviti S; DeMonti M; Guagnellini E; Scorza R Clin Cancer Res; 2001 Aug; 7(8):2344-6. PubMed ID: 11489811 [TBL] [Abstract][Full Text] [Related]
15. Matrix metalloproteinase-1 promoter polymorphism and lung cancer risk. Su L; Zhou W; Park S; Wain JC; Lynch TJ; Liu G; Christiani DC Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):567-70. PubMed ID: 15767330 [TBL] [Abstract][Full Text] [Related]
16. A functional polymorphism (-1607 1G→2G) in the matrix metalloproteinase-1 promoter is associated with development and progression of lung cancer. Liu L; Wu J; Wu C; Wang Y; Zhong R; Zhang X; Tan W; Nie S; Miao X; Lin D Cancer; 2011 Nov; 117(22):5172-81. PubMed ID: 21523769 [TBL] [Abstract][Full Text] [Related]
17. The Contribution of Matrix Metalloproteinase-1 Genotype to Oral Cancer Susceptibility in Taiwan. Sun KT; Tsai CW; Chang WS; Shih LC; Chen LY; Tsai MH; Ji HX; Hsiao CL; Liu YC; Li CY; Bau DT In Vivo; 2016; 30(4):439-44. PubMed ID: 27381606 [TBL] [Abstract][Full Text] [Related]
18. Association of Matrix Metalloproteinase-9 rs3918242 Promoter Genotypes With Colorectal Cancer Risk. Wu MH; Tzeng HE; Wu CN; Yueh TC; Peng YC; Tsai CH; Wang YC; Ke TW; Pei JS; Chang WS; Tsai CW; Bau DT Anticancer Res; 2019 Dec; 39(12):6523-6529. PubMed ID: 31810917 [TBL] [Abstract][Full Text] [Related]
19. Contribution of Matrix Metallopeptidase-1 Genotypes, Smoking, Alcohol Drinking and Areca Chewing to Nasopharyngeal Carcinoma Susceptibility. Tsai CW; Chang WS; Gong CL; Shih LC; Chen LY; Lin EY; Li HT; Yen ST; Wu CN; Bau DT Anticancer Res; 2016 Jul; 36(7):3335-40. PubMed ID: 27354591 [TBL] [Abstract][Full Text] [Related]
20. Association of Chen LH; Li CH; Wang SC; Chiu KL; Wu MF; Yang JS; Tsai CW; Chang WS; Hsia TC; Bau DT In Vivo; 2024; 38(1):365-371. PubMed ID: 38148093 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]